296 related articles for article (PubMed ID: 20337657)
1. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
Nofer JR; Brodde MF; Kehrel BE
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
[TBL] [Abstract][Full Text] [Related]
2. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence.
Nofer JR; Walter M; Assmann G
Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998
[TBL] [Abstract][Full Text] [Related]
3. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
5. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
6. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
8. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein: a potent inhibitor of inflammation.
Murphy AJ; Woollard KJ
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):710-8. PubMed ID: 19930423
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein as a modulator of platelet and coagulation responses.
van der Stoep M; Korporaal SJ; Van Eck M
Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
[TBL] [Abstract][Full Text] [Related]
11. Endothelial and antithrombotic actions of HDL.
Mineo C; Deguchi H; Griffin JH; Shaul PW
Circ Res; 2006 Jun; 98(11):1352-64. PubMed ID: 16763172
[TBL] [Abstract][Full Text] [Related]
12. [Amplification and inhibition of platelet function by serum lipoproteins].
Higashihara M
Nihon Rinsho; 1992 Feb; 50(2):282-6. PubMed ID: 1613982
[TBL] [Abstract][Full Text] [Related]
13. Signaling by the high-affinity HDL receptor scavenger receptor B type I.
Saddar S; Mineo C; Shaul PW
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):144-50. PubMed ID: 20089950
[TBL] [Abstract][Full Text] [Related]
14. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.
Andrews KL; Moore XL; Chin-Dusting JP
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):736-42. PubMed ID: 20374256
[TBL] [Abstract][Full Text] [Related]
15. Role of platelets in the pathophysiology of acute coronary syndrome.
Massberg S; Schulz C; Gawaz M
Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
[TBL] [Abstract][Full Text] [Related]
16. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
17. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
[TBL] [Abstract][Full Text] [Related]
18. Role of high density lipoproteins in the regression of atherosclerosis.
Badimon JJ; Fuster V; Badimon L
Circulation; 1992 Dec; 86(6 Suppl):III86-94. PubMed ID: 1424054
[TBL] [Abstract][Full Text] [Related]
19. Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
Nofer JR; Assmann G
Trends Cardiovasc Med; 2005 Oct; 15(7):265-71. PubMed ID: 16226682
[TBL] [Abstract][Full Text] [Related]
20. [Thrombocyte-vascular wall interaction and coronary heart disease].
Lüscher TF
Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
